SCI Abstract

search
Trends in pulmonary embolism mortality among older adults with lung cancer in the united States, 1999–2020
Trends in pulmonary embolism mortality among older adults with lung cancer in the united States, 1999–2020
This nationwide study analyzed mortality trends in U.S. adults aged 65 years and above, pulmonary embolism mortality among...
Prospective evidence of increased venous thromboembolism in hereditary hemorrhagic telangiectasia
Prospective evidence of increased venous thromboembolism in hereditary hemorrhagic telangiectasia
Hereditary Hemorrhagic Telangiectasia (HHT) is a rare vascular disease (1/5,000 prevalence) characterized by mucocutaneous...
Metabolic syndrome and venous thromboembolism: the role of abdominal obesity and sex differences
Metabolic syndrome and venous thromboembolism: the role of abdominal obesity and sex differences
Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, including abdominal obesity, insulin resistance, dy...
Association between elevated D-dimer levels and deep vein thrombosis following neurosurgery
Association between elevated D-dimer levels and deep vein thrombosis following neurosurgery
Despite thromboprophylaxis, neurosurgical patients remain at high post-operative thromboembolic risk, but early diagnosis ...
Artificial intelligence for venous thromboembolism risk stratification in surgical patients: a systematic review
Artificial intelligence for venous thromboembolism risk stratification in surgical patients: a systematic review
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant complicat...
A Growing mortality divide: demographic and regional disparities in thromboembolism with hypertension, U.S. 1999–2023
A Growing mortality divide: demographic and regional disparities in thromboembolism with hypertension, U.S. 1999–2023
Hypertension is a widespread chronic illness. Hypertension is significantly associated with thromboembolic disease, includ...
Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome
Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome
The optimal choice of oral P2Y12 inhibitor in patients with acute coronary syndrome (ACS) remains debated, particularly fo...
Insights on management of recurrence of Cancer-associated isolated distal deep vein thrombosis
Insights on management of recurrence of Cancer-associated isolated distal deep vein thrombosis
Isolated distal deep vein thrombosis (IDDVT) is the most prevalent form of deep vein thrombosis (DVT), comprising up to 50...
Bleeding events in Asian patients with cancer-associated thrombosis: a 10-year single-centre experience
Bleeding events in Asian patients with cancer-associated thrombosis: a 10-year single-centre experience
Malignancy is a well-recognised major risk factor for venous thromboembolism (VTE). While anticoagulation is the cornersto...
Pulmonary embolism mortality in the United States: a nationwide analysis
Pulmonary embolism mortality in the United States: a nationwide analysis
Pulmonary embolism (PE) remains a major cause of cardiovascular mortality in the United States. Despite therapeutic advanc...
Establishment and validation of a machine learning-based prediction model for sepsis-induced coagulopathy
Establishment and validation of a machine learning-based prediction model for sepsis-induced coagulopathy
A LightGBM model was developed to predict sepsis-induced coagulopathy (SIC) within 72 h of ICU admission using ro...
Indobufen versus aspirin for platelet inhibition: efficacy and safety insights from the INSURE and OPTION trials
Indobufen versus aspirin for platelet inhibition: efficacy and safety insights from the INSURE and OPTION trials
This study systematically compares the antiplatelet efficacy and safety of indobufen and aspirin based on two key clinical...
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Real-world data on venous thromboembolism (VTE) in Japanese patients with gynecological cancer are lacking. The GOTIC-VTE ...
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease
Anticoagulant therapy is a mainstay in the management of patients with cardiovascular disease and related conditions chara...
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Factor XIIa (FXIIa) is a plasma serine protease within the contact activation pathway. Inhibiting FXIIa could offer a viab...
Factor XI: structure, function and therapeutic inhibition
Factor XI: structure, function and therapeutic inhibition
Arterial and venous thromboembolism is a major medical concern that requires therapeutic anticoagulation in various medica...
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice
RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice
Combined deficiency of coagulation factor V (FV) and factor VIII (FVIII) is a rare bleeding disease caused by variants in ...
Thrombin generation after prothrombin complex concentrate or plasma transfusion during cardiac surgery
Thrombin generation after prothrombin complex concentrate or plasma transfusion during cardiac surgery
Thrombin generation (TG) is reduced after cardiac surgery using cardiopulmonary bypass (CPB), contributing to coagulopathy...